NEKTAR THERAPEUTICS Litigation

Mar 2, 2021

Voluntary Dismissal

The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.

Feb 4, 2021

Scheduling Order

Jan 26, 2021

Motion to Dismiss Granted

The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.

Jun 24, 2020

Scheduling Order

Jun 1, 2020

Scheduling Order

Apr 10, 2020

Motion to Dismiss

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Mar 9, 2020

Scheduling Order

Jan 24, 2020

First Amended Complaint

A new complaint has been filed on behalf of certain investors in NEKTAR THERAPEUTICS. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Nov 26, 2019

Scheduling Order

Nov 15, 2019

Appointment of Lead Plaintiff

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Nov 12, 2019

Scheduling Order

Aug 20, 2019

Scheduling Order

Aug 20, 2019

Scheduling Order

Aug 19, 2019

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in NEKTAR THERAPEUTICS.